Literature DB >> 15176666

Anti-SS-A/Ro reactivity in patients with Vogt-Koyanagi-Harada syndrome.

M Shinzato, J H Yamamoto, C E Hirata, E Olivalves, E Bonfá.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15176666     DOI： 10.1191/0961203304lu515xx

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  5 in total

1.  Vogt-Koyanagi-Harada disease in an 8-year-old boy.

Authors:  Budi Setiabudiawan; Feti Karfiati; Reni Ghrahani; Gartika Sapartini; Indra Sahril
Journal:  Asia Pac Allergy       Date:  2011-07-28

2.  Increased frequency of anti-retina antibodies in asymptomatic patients with chronic t. gondii infection.

Authors:  Sylvia Regina Temer Cursino; Thaís Boccia da Costa; Joyce Hisae Yamamoto; Luciana Regina Meireles; Maria Antonieta Longo Galvão Silva; Heitor Franco de Andrade Junior
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

3.  Neurosarcoidosis Occurring 6 Years after Onset of Vogt-Koyanagi-Harada Disease.

Authors:  Yoshihide Sehara; Hideaki Otsuka; Shinichi Sakamoto; Yoshihito Ando; Mikio Sawada
Journal:  Case Rep Ophthalmol       Date:  2019-01-24

Review 4.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

Review 5.  Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment.

Authors:  Laura Girasoli; Diego Cazzador; Roberto Padoan; Ennio Nardello; Mara Felicetti; Elisabetta Zanoletti; Franco Schiavon; Roberto Bovo
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.